Editas Medicine, Inc.

EDIT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$2.65+2.71%

2026-08-03

Financials

Valuation Metrics

Editas Medicine, Inc.'s Market Cap is $259M. At end of 2025 it was $182M. Ranked #2991 of 3,112 in US market (top 96%), #1352 of 1,445 on NASDAQ (top 94%), #248 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 92%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$259M	US#2,991/3,112 Sec#248/269
Revenue	$39M	US#2,878/3,112 Sec#162/269
Net Income	$-109M	US—/3,112 Sec—/269
Total Assets	$149M	US#3,005/3,112 Sec#255/269
Net Assets	$4M	US#3,002/3,112 Sec#262/269
Value
P/B	58.86x	US#2,940/3,112 Sec#253/269
P/S	6.71x	US#2,474/3,112 Sec#100/269
FCF Yield	-54.38%	US—/3,112 Sec—/269
Profitability
ROA	-72.96%	US#3,024/3,112 Sec#250/269
Op. Margin	-297.50%	US#2,879/3,112 Sec#151/269
Revenue Growth	-39.22%	US#2,855/3,112 Sec#158/269
Financial Health
Debt Ratio	3287.89%	US#2,954/3,112 Sec#261/269
Total Debt	$72M	US#2,468/3,112 Sec#137/269
FCF	$-141M	US#2,669/3,112 Sec#183/269
Cash	$124M	US#2,083/3,112 Sec#164/269
Current Ratio	3.22x	US#737/3,112 Sec#187/269
Performance
1Y Return	8.61%	US#1,955/3,112 Sec#187/269
1M Return	-27.40%	US#3,047/3,112 Sec#252/269
From 52W High	-41.63%	US#2,586/3,112 Sec#200/269
1Y MDD	-59.76%	US#2,715/3,112 Sec#213/269
Trading
Volume	759,129 shares	US#1,735/3,112 Sec#169/269
Trading Value	$2M	US#2,918/3,112 Sec#244/269
Per Share
EPS	$-1.80	US—/3,112 Sec—/269
BPS	$0.31	US#2,700/3,112 Sec#227/269